Poolbeg Pharma

What role is AI/ML playing in drug development?

Artificial Intelligence (AI) and Machine Learning (ML) can be described as a branch of computer science, statistics, and engineering that uses algorithms or models to perform tasks and exhibit behaviors

Poolbeg Pharma

How AI is transforming drug discovery

The pharmaceutical industry is continually seeking novel approaches to create and identify effective treatments that cater to medical requirements. The procedure of discovering drugs is a daunting process that demands

Poolbeg Pharma

The future of AI in the pharmaceutical industry

Artificial intelligence is revolutionising the pharmaceutical and biotechnology industries. Its unparalleled power to make predictions based on large data sets is advancing understanding of diseases, improving diagnostic speed and accuracy,

Poolbeg Pharma

AI and Drug Discovery

The use of artificial intelligence (AI) in drug discovery is revolutionizing the pharmaceutical industry. AI-driven drug discovery has the potential to reduce the time and cost of drug development, while also improving

Poolbeg Pharma

Professor Siobhan McClean on Vaccine Candidates

Poolbeg Pharma plc (LON:POLB) is a clinical stage infectious disease pharmaceutical company, with a novel capital light clinical model which enables us to develop multiple products faster and more cost

Poolbeg Pharma

Poolbeg Pharma publishes Annual Results

Poolbeg Pharma plc (LON:POLB, OTCQB: POLBF’), a leading biopharmaceutical company focusing on infectious and prevalent diseases with a high unmet medical need, has confirmed that the Company’s Annual Report and Accounts for the

Poolbeg Pharma

Revolutionising drug discovery

Renowned futurist Ray Kurzweil has predicted a seismic shift in the balance of power between man and machine: a momentous occasion he calls “the singularity”. This prophecy foresees a time,

Poolbeg Pharma

The age of AI has begun

Health I see several ways in which AIs will improve health care and the medical field. For one thing, they’ll help health-care workers make the most of their time by

Diversified Energy Company plc
Diversified Energy CEO Rusty Hutson discusses the Maverick Natural Resources acquisition and its impact on growth, margins, and sustainability goals.
Cerillion
In an exclusive interview with DirectorsTalk, Cerillion plc CEO Louis Hall discusses the $11.4 million telecom contract and its impact on the company's growth strategy.
Pan African Resources
Discover the success behind Pan African Resources plc and its outperformance as discussed by Gervais Williams, Co-Fund Manager of Diverse Income Trust plc.
One Health Group plc
In an exclusive interview, One Health Group plc CEO Adam Binns discusses the company's partnership with the NHS, operational growth, and future plans.
Ilika plc
In an exclusive interview, Ilika plc CEO Graeme Purdy discusses progress with Stereax & Goliath, exciting technical milestones, and competition with peers.
Arbuthnot Banking Group plc
Gervais Williams discusses Arbuthnot Banking Group plc's success and potential growth in an exclusive interview with DirectorsTalk.
Discover the latest trends in commercial real estate investment, from shifting market landscapes to emerging opportunities in private credit financing.
Volta Finance
Discover the allure of Collateralized Loan Obligations (CLOs) and how they offer high yields and structured returns to savvy investors in today's market.
Fidelity China Special Situations
China's AI sector is booming thanks to DeepSeek's breakthrough, attracting investment and reshaping the tech rivalry with the U.S. Learn more here.
Fidelity Special Values
The British Pound is gaining momentum against the US Dollar, with potential for a test of the 2025 high. Trade tensions and central banks drive volatility.
Fidelity European Trust
European markets saw a lift driven by key earnings reports, with notable movements in sectors like automobiles and financial services. Read more here.
Beeks Financial Cloud Group Plc secures Nasdaq as the latest customer for its Exchange Cloud service, solidifying its leadership in low-latency solutions.
Agronomics Limited (LON:ANIC) shapes the future of sustainable food production with strategic investments in cellular agriculture. Cavendish report highlights its progress in 2024.
SAE Renewables (LON:SAE) advances energy ambitions with £1.3M payment for Uskmouth BESS project. Analyst sees positive impact on future projects.
hVIVO plc
hVIVO plc achieves milestone with £3.2 million hLAB contract, showcasing growth in laboratory services. Read about the company's latest achievement here.
Greggs
Greggs plc (LON:GRG) shines in tough market conditions, delivering solid FY24 results with revenue of £2,014 million and strong growth.